You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昭衍新藥(603127.SH):股東顧美芳及一致行動人持股比例降至9.83%
格隆匯 05-24 18:32

格隆匯5月24日丨昭衍新藥(603127.SH)公佈,公司於2021年5月24日收到股東顧美芳減持公司股份的通知,顧美芳於2021年5月17日-2021年5月24日期間,通過上海證券交易所集中競價的方式累計減持公司股份46.49萬股,減持數量佔公司總股份的比例為0.17%。

顧曉磊、顧美芳合計披露了多次股份減持計劃並完成減持。在減持期間,由於公司實施了多次資本公積轉增股本以及股權激勵計劃,所以公司總股份相應發生了變化。

因公司於2021年2月26日完成H股上市及於3月19日行使H股超額配售權,公司累計發行H股份4336.56萬股,因此公司總股份由2.27億股變為2.71億股。

本次權益變動後,信息披露義務人及其一致行動人合計持有公司的股份比例由14.83%變為9.83%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account